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BACKGROUND: One of the rare causes of venous thromboembolism in pregnancy is antithrombin III 
deficiency. Antithrombin III deficiency is estimated to carry a 30% risk of venous thrombotic 
complication during each pregnancy and postpartum.  
CASE DETAILS: We present thea case of a A 21-year-old pregnant woman (Para 1+) with a history of 
large atrial septal defect repair at our hospital (Imam Ali Hospital, 2 May 2014). The patient, with 
unknown history of antithrombin III deficiency, was admitted at our emergency center with dyspnea and 
chest pain for the rule out of tamponade. She presented with a right atrial thrombosis in the second 
trimester of pregnancy despite the use of therapeutic doses of heparin and warfarin in the postoperative 
period as thromboembolic prophylaxis. The risk of warfarin emberyopaty led to termination of 
pregnancy, and successful redo-cardiac surgery outcome was achieved with the combined use of 
therapeutic anticoagulation and regular plasma-derived antithrombin concentrate infusions to normalize 
her antithrombin levels.  
CONCLUSSION: She recovered from the operation uneventfully, and wad discharged in the 12
th
 
postoperative day. In the 6
th
 month of follow-up, antithrombin III increased to 70% in more stable level 
and transethoracic echocardiography showed no recurrence of right atrial thrombus formation. This 
case leads to further debate regarding whether full anticoagulation should be a worthy preventive 
measure for venous thromboembolic prophylaxis after an open heart surgery complicated by pregnancy 
in a women with inherited antithrombin III deficiency. This point may become more relevant as further 
experience is gained with the use of recombinant human antithrombin in known cases during open 
cardiac surgery. 





Pregnancy is a natural thrombophilia state (TS), 
and the risk of thromboembolic events (TEE) in 
women with acquired or congenital antithrombin 
III deficiency (ATIIID) is increased to four or 
fivefold compared to non-pregnant women. If 
pregnancy was associated with congenital ATIIID 
and other acquired disturbance of coagulation 
factors such as cardiopulmonary bypass (CPB), 
this risk would increase to tenfold (1,2).  TEE of  
pregnancy  occurred in 75%, 20% and 5% in 
venous, arterial and venous-arterial system 
respectively (1,2). The true incidence of venous 
thromboemboli (VTE) is well known in pregnancy 
and could be estimated  between 0.45 to 1.5 per 
1000 pregnancies. The most common cause of 
VTE in pregnancy is a history of thrombosis that 
its physiopathology base was not defined with the 
current laboratory exam. The second most 
common risk factor for VTE in pregnancy is 
thrombophilia state (TS) (3,4). TS was diagnosed 
in 35% of pregnant women who suffered from 
VTE in the pre or in the postpartum period. In this 
article, we present a unique case of right atrial 
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thrombus (RAT) after an atrial septal defect 
(ASD) repair due to congenital ATIIID in a 
pregnant woman.The patient was treated with 
fresh frozen plasma, intravenous injections of 
heparin and oral low-dose aspirin therapy, 
intravenous infusions of ATIII concentrate and 
surgical resection of thrombus in the right atrium. 
Pregnancy was terminated due to risk of warfarin 
emberyopathy after correction of ATIIID on the 
11
th
 day of operation (5,6). The available literature 
strategy for therapy of RAT in ATIIID in 
pregnancy is limited and the surgical approach, 





A 21-year-old woman, with a history of ASD 
repair in 5 months earlier  and with unknown 
history of ATIIID, was admitted to our hospital at 
the 9
th
 week of gestation with dyspnea and chest 
pain. She did not have any familial history of 
thrombophilia or ATIIID, or previous VTE. TTE 
confirmed presence of a large thrombus in the 
right atrium (Figure 1). Abdominal ultrasound 
revealed live fetus of 8 weeks old with normal 
heart rate (Figure 2). Screening tests for routine 
coagulation test, including bleeding time (BT), 
prothrombin time (PT), activated partial 
prothrombin time (aPTT), fibrinogen and platelet 
function were normal. Her hepatic function tests 
were also normal. Blood biochemistry results
 
were 
unremarkable, except for prolonged erythrocyte 
sedimentation rate. Thrombophilia assay except 




antibodies, HLA-B5, anti-double strand DNA 
antibody, HLA-B27, anti-nuclear antibody, 
rheumatoid factor, proteins C and S, anti-
phospholipids antibodies, factor V Leiden, 
activated protein C resistance, homocystein level , 
factors II, VII, VIII and IX. Serum level of 
antithrombin III was 55% of normal range of 80-
140%. The previous ASD operation was 
performed by CPB and the use of the fresh 
pericardial patch. To reduce further 
thromboemboli risk, she was managed with fresh 
frozen plasma and anti-thrombin concentrate and 
then underwent emergency surgical removal of the 
clot. During postcardiac surgery, fresh frozen 
plasma and anti-thrombin concentrate were 
continued and followed after termination of 
pregnancy. Heparin resistance was observed 
during previous CPB and in the current operation, 
and for maintenance of activated clotting time 
(ACT) level at 470 seconds, a further dose of 
heparin was infused to the pump prime. As to our 
routine postoperative strategy, intravenous heparin 
was started immediately following ASD surgery. 
Warfarin was administered orally, 12 hours after 
surgery to maintain the international normalized 
ratio (INR) at 2-2.5 level. Her previous ASD 
surgery was uneventful. In the 3
th
 month of 
postoperative period, with a normal cardiac TTE 
result, the warfarin was held and   then the patient 




Figure 1: Abdominal sonography shows 8 weeks’ 
live fetu (black arrow) 
 
 
Figure 2: Shows right atrial thrombus (black 
arrow) 
 
Two months later, she was admitted to our center 
with dyspnea and an unwished pregnancy. On 
physical examination, her blood pressure, pulse 
rate and respiratory rate were 140/70, 89 and 24 
respectively. No sign of edema or 
thrombophelebitis was noted in lower extremities. 
Respiratory sound was normal in chest 
examination. Other clinical findings were 
unremarkable. The patient was admitted for 
evaluation of suspected VTE based on previous 
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ASD repair. TTE showed a large thrombus in the 
right atrium with no accompanying clot in other 
cardiac chambers, pulmonary arteries or vena 
cava. Abdominal ultrasound revealed an 8 weeks 
old fetus with normal heart rate. Despite previous 
postoperative intravenous and oral anticoagulant 
therapy at appropriate course and dose, thrombus 
occurred in the right atrium although; complete 
thrombophilia screening tests except to ATIIID 
test were normal. The patient was treated with 4 
units of fresh frozen plasma after receiving a 
loading dose and received continuous intra venous 
heparin. Although the patient received another 
large bolus dose within 6 hours, heparin infusion 
caused a temporary elevation in the serum aPTT 
level. Therefore, antithrombin concentrate was 
initiated with a loading dose of 50 iu/kg, and the 
same dose was repeated at 12 hours interval, 
which elevated the serum AT level from 55% to 
100%. The aPTT, prolonged to 76 seconds, and 
subsequent examination showed serum stability of 
the AT level compared to much more variability 
that had been observed prior to administration of 
AT concentrate therapy. The patient continued to 
receive IV heparin and AT concentrate for seven 
days. Following management of heparin resistance 
caused by ATD, the patient underwent a redo 
operation with midline sternotomy and aortic and 
bicava cannulation. With heparin infusion 
(activating clotting time of >470 second) and CPB 
establishment, ascending aorta cross clamped and 
cold cardioplegin infused antegradly in the aortic 
root. The right atrium was opened, and the large 
organized thrombus that was attached with a small 
pedicle to the lateral wall of the right atrium was 









Figure 4: Shows intraoperative view of thrombus 
with narrow pedicle  
 
The clot was not related to pericardial patch that 
was used in previous ASD closure. Pathological 
exam revealed fibrin and red cells in resected right 
atrial mass (Figure 5). At the postoperative period, 
AT concentrate was continued twice weekly 
accompanied by heparin and ASA usage. 
Ultimately, due to risk of warfarin emberyopathy, 
the pregnancy was terminated. The termination of 
pregnancy was associated with immediate 
elevation of the AT level to 65% of expected 
serum level. The aPTT, test examined regularly, 
that stabilized at 48 seconds and the AT 
concentrate was discontinued following 
termination of pregnancy. In the 6
th
 month of 
follow-up, serum level of AT reached to 70% of 
predicted level, but was not normalized lower 









Figure 5: Shows histology of thrombus consists of 




RAT is a very rare event following cardiac surgery 
on women who had an unwished early 
postoperative pregnancy. Thrombophilia, behcet̓s 
syndrome, myeloproliferative disorder, hepatic 
failure with transient antithrombin deficiency, 
acquired or congenital deficiency of protein C or 
ATIII and hepatocellular carcinoma are the most 
frequent causes of RAT (7,8). ATIIID is classified 
into acquired and congenital types. Pregnancy is 
considered as an acquired type. In some pregnant 
women, a gradual dropping of serum level of anti-
thrombin (AT) activity occurrs in the late trimester 
of pregnancy, which is not related to hypertension, 
preeclampsia. If combined with congenital type as 
in our patient, it may be associated with serious 
consequence. The reducuction in AT level in 
acquired type continues until 24 hours following 
delivery or termination of pregnancy. If AT serum 
level as a most important natural agent for the 
anti-coagulation of blood remains in the lower 
level by delaying in the delivery or termination of 
pregnancy, it may be associated with dangerous 
events like a TE in women, especially when other 
thrombophilia states such as cardiac surgery and 
CPB are added to others risk factors (9). The risk 
of TE increases tenfold in the presence of 
preeclampsia or multi-fetal pregnancy. Some, 
pregnant women with ATIIID may be at risk of 
acute fatty liver occurrence (10). Of women with 
ATIIID without a history of previous thrombosis, 
31% will develop a TE during pregnancy. In 
women with a history of thrombus formation, this 
rate is increased to 49% (11).  Cardiopulmonary 
bypass (CPB) may be associated with 
postoperative coagulophaty and enhanced 
thrombus formation in patients with congenital 
ATIIID.  
Our data about RAT after open cardiac 
surgery with or without associated congenital 
ATIIID is exceedingly scanty.  In this article, we 
presented a unique case of RAT after an ASD 
repair due to mild congenital ATIIID that had 
other predisposing risk factors in enhancing 
thrombophilia state of pregnancy and subsequent 
thrombus formation (12). These risk factors 
include CPB use, surgery in the right atrium with 
its specific geometry and relatively blood stasis, a 
TS of pregnancy and finally ATIIID (13). 
However, our data about RAT after open cardiac 
surgery is exceedingly scanty and our clinical 
experience in diagnosis and treatment of RAT 
formation in antithrombin deficiency in pregnancy 
is limited.  
ATIIID has been reported with variable range 
of incidence in pregnancy. This variability could 
be related to controversy in the definition of ATD. 
In some case series, the thresholds of ATIIID have 
been considered at a higher level (<65%) than in 
other series that deficiency defined at a lower level 
(<50%). This challenge in the definition could be 
observed in related studies (14). The patient 
presented here was a 21-year-old pregnant woman 
admitted with RAT on the 8
th
 week of pregnancy. 
This clinical case report suggests that the surgeon 
has to appreciate that ATIIID is a very rare 
phenomenon, especially in pregnant women after 
cardiac surgery, and correct management should 
be started as soon as possible to avoid a serious 
outcome. The first inherited case of ATD was 
diagnosed in 1965 as a thrombophilia state, but 
then no case of ATIIID was reported in 
postcardiac surgery in pregnant woman (15,16). 
In conclusion, in the presence of 
postoperative spontaneous intracardiac thrombosis 
despite the use of anticoagulants in young patients, 
inherited antithrombin deficiency must be 
considered. Immobilization, intracardiac 
procedures, use of foreign for repair of 
intracardiac defect, postoperative acute or chronic 
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